What is LIFS stock price today?

LIFS (Life Stem Genetics) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is LIFS stock going up or down today?

LIFS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy LIFS stock now?

The decision to buy LIFS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is LIFS a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for LIFS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is LIFS stock overvalued or undervalued?

Use our DCF valuation calculator to determine if LIFS is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is LIFS's P/E ratio?

P/E ratio data for LIFS will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is LIFS's market cap?

LIFS (Life Stem Genetics) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is LIFS's price to book ratio?

LIFS trades at a price-to-book (P/B) ratio of 0.13, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does LIFS pay dividends?

LIFS does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is LIFS's dividend yield?

LIFS does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is LIFS stock a good long-term investment?

LIFS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is LIFS's revenue growth rate?

Revenue growth data for LIFS is available on our dashboard with detailed financial statement analysis.

Profitability metrics for LIFS are available on our dashboard with complete income statement analysis.

What are the risks of investing in LIFS?

Key risks for LIFS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does LIFS compare to its competitors?

Compare LIFS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize LIFS's performance and positioning.

What is LIFS's stock price target for 2026?

Our AI model provides price targets for LIFS based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about LIFS?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for LIFS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is LIFS's next earnings report?

LIFS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

LIFS - Life Stem Genetics

NYSE * Financial Services * Shell Companies

$0.00

+$0.00 (+0.00%)

About Life Stem Genetics

Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide. Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti-viral therapy; and adistem stem cell treatments for orthopedics, neurological, and lung diseases. Life Stem Genetics Inc. has a strategic collaborative agreement with American CryoStem Corporation. The company was founded in 2012 and is based in East Stroudsburg, Pennsylvania.

LIFS Key Statistics

Market Cap

$0.07M

P/B Ratio

0.13

How LIFS Compares to Peers

LIFS is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
LIFS(This stock)	$73.75K	N/A	0%	0.0%	-
JPMJpmorgan Chase	$835.95B	14.8	0%	0.3%	vs JPM
BACBank Of	$389.84B	13.5	0%	0.3%	vs BAC
WFCWells Fargo	$246.89B	12.4	0%	0.3%	vs WFC
GSGoldman Sachs	$267.08B	16.4	0%	0.3%	vs GS
VVisa Inc	$609.09B	29.7	0%	0.5%	vs V

Life Stem Genetics Company Information

Headquarters: 3300 Parker Lane, East Stroudsburg, PA, United States, 18301, undefined
Sector: Financial Services
Industry: Shell Companies

Data Updated: April 17, 2026 at 6:41 PM EDT

Ready to invest in LIFS?

Commission-free trading available. Affiliate links.

Upcoming Events for LIFS

Dashboard

Enter a ticker to analyze